The Female Health Company (“FHC” or the “Company”) manufactures, markets and sells the FC2 female condom, the only currently available product under a woman’s control that is approved by the U.S. Food and Drug Administration (FDA), which provides dual protection against unintended pregnancy and sexua
... morelly transmitted infections (“STIs”), including HIV/AIDS. In October 2009, the Company completed the transition from its first generation product, FC1, to its second generation product, FC2, and production of FC1 ceased. Although FC1 production has ceased, the Company retains ownership of certain world-wide rights to FC1, as well as various patents, regulatory approvals and other intellectual property related to FC1.The Female Health Company is publicly traded on the NASDAQ-CM stock exchange under the symbol "FHCO".less
Safe Harbor Statement
The statements in this release which are not historical fact are "forward looking statements" as ...
Vice President & C.F.O.
515 N. State Street
Chicago, IL, 60654
United States of America